1. Home
  2. ADSK vs IQV Comparison

ADSK vs IQV Comparison

Compare ADSK & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Autodesk Inc.

ADSK

Autodesk Inc.

HOLD

Current Price

$207.36

Market Cap

45.4B

Sector

Technology

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$270.97

Market Cap

43.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADSK
IQV
Founded
1982
1982
Country
United States
United States
Employees
N/A
93000
Industry
Computer Software: Prepackaged Software
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.4B
43.1B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
ADSK
IQV
Price
$207.36
$270.97
Analyst Decision
Buy
Strong Buy
Analyst Count
26
16
Target Price
★ $335.04
$227.13
AVG Volume (30 Days)
★ 1.9M
1.3M
Earning Date
05-21-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
2.15
★ 4.67
EPS
★ 4.64
1.61
Revenue
$7,206,000,000.00
★ $9,739,000,000.00
Revenue This Year
$15.35
$6.77
Revenue Next Year
$10.36
$5.89
P/E Ratio
★ $45.13
$167.76
Revenue Growth
17.53
★ 41.60
52 Week Low
$185.50
$154.50
52 Week High
$326.18
$277.40

Technical Indicators

Market Signals
Indicator
ADSK
IQV
Relative Strength Index (RSI) 35.05 61.81
Support Level $202.16 $159.91
Resistance Level $218.90 $271.80
Average True Range (ATR) 6.53 6.44
MACD -1.32 -0.77
Stochastic Oscillator 15.73 74.11

Price Performance

Historical Comparison
ADSK
IQV

About ADSK Autodesk Inc.

Founded in 1982, Autodesk is a multinational software company best known for pioneering computer-aided design, or CAD, with its AutoCAD product. Nowadays, Autodesk provides design software for a variety of verticals, including architecture & construction, manufacturing, and media & entertainment. Autodesk products have been used in some of the world's most iconic landmarks, like Burj Khalifa, and well-known movie titles like Avatar.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: